Cite
Bertozzi S, Londero AP, Viola L, et al. TFEB, SIRT1, CARM1, Beclin-1 expression and PITX2 methylation in breast cancer chemoresistance: a retrospective study. BMC Cancer. 2021;21(1):1118doi: 10.1186/s12885-021-08844-y.
Bertozzi, S., Londero, A. P., Viola, L., Orsaria, M., Bulfoni, M., Marzinotto, S., Corradetti, B., Baccarani, U., Cesselli, D., Cedolini, C., & Mariuzzi, L. (2021). TFEB, SIRT1, CARM1, Beclin-1 expression and PITX2 methylation in breast cancer chemoresistance: a retrospective study. BMC cancer, 21(1), 1118. https://doi.org/10.1186/s12885-021-08844-y
Bertozzi, Serena, et al. "TFEB, SIRT1, CARM1, Beclin-1 expression and PITX2 methylation in breast cancer chemoresistance: a retrospective study." BMC cancer vol. 21,1 (2021): 1118. doi: https://doi.org/10.1186/s12885-021-08844-y
Bertozzi S, Londero AP, Viola L, Orsaria M, Bulfoni M, Marzinotto S, Corradetti B, Baccarani U, Cesselli D, Cedolini C, Mariuzzi L. TFEB, SIRT1, CARM1, Beclin-1 expression and PITX2 methylation in breast cancer chemoresistance: a retrospective study. BMC Cancer. 2021 Oct 18;21(1):1118. doi: 10.1186/s12885-021-08844-y. PMID: 34663249; PMCID: PMC8524961.
Copy
Download .nbib